Avalo Therapeutics (AVTX) Leases (2019 - 2026)
Avalo Therapeutics posted quarterly Leases of $268000.0 for Q1 2026, down 56.42% year-on-year from $615000.0 in Q1 2025, and down 20.24% on a QoQ basis from $336000.0 in Q4 2025.
Avalo Therapeutics (AVTX) has 8 years of Leases data on file, last reported at $268000.0 in Q1 2026.
- For the quarter ending Q1 2026, Leases fell 56.42% year-over-year to $268000.0; the trailing twelve-month figure through Mar 2026 stood at $268000.0 (down 56.42% YoY), and the FY2025 full-year result was $336000.0, down 54.66% from the prior year.
- Leases for Q1 2026 stood at $268000.0, down from $336000.0 in the prior quarter.
- Across five years, Leases topped out at $1.9 million in Q1 2022 and bottomed at $268000.0 in Q1 2026.
- The 5-year median for Leases is $1.3 million (2024), against an average of $1.2 million.
- The widest annual swing landed in 2022, when Leases soared 159.74%; it then sank 64.71% in 2025.
- A 5-year view of Leases shows it stood at $1.8 million in 2022, then dropped by 24.06% to $1.3 million in 2023, then sank by 44.24% to $741000.0 in 2024, then slumped by 54.66% to $336000.0 in 2025, then decreased by 20.24% to $268000.0 in 2026.
- The last three Leases figures came in at $268000.0 (Q1 2026), $336000.0 (Q4 2025), and $402000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 61,822.50 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 189.30 Mn |
| 10 | Avalo Therapeutics | 317.29 Mn | 317.29 Mn | - | 268,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 268,000.00 |
| Dec 31, 2025 | 336,000.00 |
| Sep 30, 2025 | 402,000.00 |
| Jun 30, 2025 | 487,000.00 |
| Mar 31, 2025 | 615,000.00 |
| Dec 31, 2024 | 741,000.00 |
| Sep 30, 2024 | 1.14 Mn |
| Jun 30, 2024 | 1.21 Mn |
| Mar 31, 2024 | 1.28 Mn |
| Dec 31, 2023 | 1.33 Mn |
| Sep 30, 2023 | 1.39 Mn |
| Jun 30, 2023 | 1.46 Mn |
| Mar 31, 2023 | 1.68 Mn |
| Dec 31, 2022 | 1.75 Mn |
| Sep 30, 2022 | 1.81 Mn |
| Jun 30, 2022 | 1.88 Mn |
| Mar 31, 2022 | 1.94 Mn |
| Dec 31, 2021 | 2.00 Mn |
| Sep 30, 2021 | 698,000.00 |
| Jun 30, 2021 | 773,000.00 |
| Mar 31, 2021 | 846,000.00 |
| Dec 31, 2020 | 918,000.00 |
| Sep 30, 2020 | 983,411.00 |
| Jun 30, 2020 | 1.06 Mn |
| Mar 31, 2020 | 710,230.00 |
| Dec 31, 2019 | 718,626.00 |
| Sep 30, 2019 | 719,113.00 |
| Jun 30, 2019 | 728,138.00 |
| Mar 31, 2019 | 737,658.00 |